Cardiovascular Considerations of JAK Inhibitors in Patients With Hematologic Malignancies

Orly Leiva, Monica Ferrante, Sydney Lupo, Angie E. Seo, Gabriela Hobbs, Michelle Bloom, Michael Garshick

Open source

DOI
10.1016/j.jaccao.2026.07.010
Published
2026-09
Container
JACC: CardioOncology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jaccao.2026.07.010,
  title = {Cardiovascular Considerations of JAK Inhibitors in Patients With Hematologic Malignancies},
  author = {Orly Leiva and Monica Ferrante and Sydney Lupo and Angie E. Seo and Gabriela Hobbs and Michelle Bloom and Michael Garshick},
  year = {2026},
  journal = {JACC: CardioOncology},
  doi = {10.1016/j.jaccao.2026.07.010},
  url = {https://doi.org/10.1016/j.jaccao.2026.07.010}
}

RIS

TY  - JOUR
TI  - Cardiovascular Considerations of JAK Inhibitors in Patients With Hematologic Malignancies
AU  - Orly Leiva
AU  - Monica Ferrante
AU  - Sydney Lupo
AU  - Angie E. Seo
AU  - Gabriela Hobbs
AU  - Michelle Bloom
AU  - Michael Garshick
PY  - 2026
JO  - JACC: CardioOncology
DO  - 10.1016/j.jaccao.2026.07.010
UR  - https://doi.org/10.1016/j.jaccao.2026.07.010
ER  - 

APA

Leiva, O., Ferrante, M., Lupo, S., Seo, A. E., Hobbs, G., Bloom, M., & Garshick, M. (2026). Cardiovascular Considerations of JAK Inhibitors in Patients With Hematologic Malignancies. JACC: CardioOncology. https://doi.org/10.1016/j.jaccao.2026.07.010

Source records